The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells: from clinic to bench—a critical review
J Szenajch, G Wcislo, JY Jeong, C Szczylik… - … et Biophysica Acta (BBA …, 2010 - Elsevier
Recombinant human erythropoietin (rhEPO) has been used clinically to alleviate cancer-and
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
[引用][C] The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells: From clinic to bench-a critical review
J SZENAJCH - Biochim Biophys Acta, 2010 - cir.nii.ac.jp
The role of erythropoietin and its receptor in growth, survival and therapeutic response of
human tumor cells: From clinic to bench-a critical review | CiNii Research CiNii 国立情報学 …
human tumor cells: From clinic to bench-a critical review | CiNii Research CiNii 国立情報学 …
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench-a critical review.
J Szenajch, G Wcislo, JY Jeong, C Szczylik… - … et Biophysica Acta, 2010 - europepmc.org
Recombinant human erythropoietin (rhEPO) has been used clinically to alleviate cancer-and
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench-a critical review
J Szenajch, G Wcislo, JY Jeong… - … et biophysica acta, 2010 - pubmed.ncbi.nlm.nih.gov
Recombinant human erythropoietin (rhEPO) has been used clinically to alleviate cancer-and
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
[PDF][PDF] The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench—a critical review
J Szenajch, G Wcislo, JY Jeong, C Szczylik… - … et Biophysica Acta, 1806 - academia.edu
Jolanta Szenajch a, b, Gabriel Wcislo b, Jee-Yeong Jeong c, e, Cezary Szczylik b, Laurie
Feldman d, e,⁎ a Laboratory for Molecular Oncology, Military Institute of Medicine, Szaserow …
Feldman d, e,⁎ a Laboratory for Molecular Oncology, Military Institute of Medicine, Szaserow …
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells
J Szenajch, G Wcislo, JY Jeong, C Szczylik… - BBA-Reviews on …, 2010 - infona.pl
Recombinant human erythropoietin (rhEPO) has been used clinically to alleviate cancer-and
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
chemotherapy-related anemia. However, recent clinical trials have reported that rhEPO also …
[引用][C] The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells
J Szenajch, G Wcislo, JY Jeong, C Szczylik… - … et Biophysica Acta …, 2010 - cir.nii.ac.jp
The role of erythropoietin and its receptor in growth, survival and therapeutic response of
human tumor cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
human tumor cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …